Mohsin Sayyed

Mohsin Sayyed has a strong background in research and development in the biotechnology and pharmaceutical industry. Mohsin started their career as a Project Trainee at Serum Institute of India Limited, where they conducted a dissertation on nasopharyngeal carriage study. Mohsin then worked as a Research and Development Officer and Executive Officer R&D at Serum Institute of India Pvt. Ltd., where they developed various assays for the release of vaccines.

After that, Mohsin joined Syngene International Limited as an Associate Scientist, where they developed and performed immuno-oncology based assays to assess the efficacy of novel antibodies for immune cancer therapy. Their work involved using cell-based assays, flow cytometry, and other techniques.

Later, Mohsin worked as a Research A. Scientist II at Lady Davis Institute - Jewish General Hospital, where they further contributed to research projects. Currently, they hold the position of Principal Analytical Specialist at BlueRock Therapeutics, where they continue to utilize their expertise in analytics and research.

Mohsin Sayyed obtained a Master of Technology (M.Tech.) degree in Biotechnology from Dr. D Y Patil Biotechnology and Bioinformatics Institute from 2008 to 2013. Before that, they completed their Higher Secondary School education in Science from Sangameshwer College in Solapur from 2006 to 2008. Their earlier education includes attending Rogers English Medium School from 1994 to 2006. In 2020, they obtained the certification for Verified International Academic Qualifications from World Education Services.